Literature DB >> 15814524

Hepatitis B virus DNA-negative dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain.

Tatsuji Kimura1, Nobuhiko Ohno, Nobuo Terada, Akinori Rokuhara, Akihiro Matsumoto, Shintaro Yagi, Eiji Tanaka, Kendo Kiyosawa, Shinichi Ohno, Noboru Maki.   

Abstract

DNA-negative Dane particles have been observed in hepatitis B virus (HBV)-infected sera. The capsids of the empty particles are thought to be composed of core protein but have not been studied in detail. In the present study, the protein composition of the particles was examined using new enzyme immunoassays for the HBV core antigen (HBcAg) and for the HBV precore/core proteins (core-related antigens, HBcrAg). HBcrAg were abundant in fractions slightly less dense than HBcAg and HBV DNA. Three times more Dane-like particles were observed in the HBcrAg-rich fraction than in the HBV DNA-rich fraction by electron microscopy. Western blots and mass spectrometry identified the HBcrAg as a 22-kDa precore protein (p22cr) containing the uncleaved signal peptide and lacking the arginine-rich domain that is involved in binding the RNA pregenome or the DNA genome. In sera from 30 HBV-infected patients, HBcAg represented only a median 10.5% of the precore/core proteins in enveloped particles. These data suggest that most of the Dane particles lack viral DNA and core capsid but contain p22cr. This study provides a model for the formation of the DNA-negative Dane particles. The precore proteins, which lack the arginine-rich nucleotide-binding domain, form viral RNA/DNA-negative capsid-like particles and are enveloped and released as empty particles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814524     DOI: 10.1074/jbc.M501564200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Hepatitis B Virus-Encoded MicroRNA Controls Viral Replication.

Authors:  Xi Yang; Hongfeng Li; Huahui Sun; Hongxia Fan; Yaqi Hu; Min Liu; Xin Li; Hua Tang
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

2.  Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection.

Authors:  Akihiro Matsumoto; Eiji Tanaka; Susumu Morita; Kaname Yoshizawa; Takeji Umemura; Satoru Joshita
Journal:  J Gastroenterol       Date:  2012-02-29       Impact factor: 7.527

3.  Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B.

Authors:  Kazunori Kawaguchi; Masao Honda; Hajime Ohta; Takeshi Terashima; Tetsuro Shimakami; Kuniaki Arai; Taro Yamashita; Yoshio Sakai; Tatsuya Yamashita; Eishiro Mizukoshi; Takuya Komura; Masashi Unoura; Shuichi Kaneko
Journal:  J Gastroenterol       Date:  2017-08-28       Impact factor: 7.527

4.  Chimeric rabbit/human Fab antibodies against the hepatitis Be-antigen and their potential applications in assays, characterization, and therapy.

Authors:  Xiaolei Zhuang; Norman R Watts; Ira W Palmer; Joshua D Kaufman; Altaira D Dearborn; Joni L Trenbeath; Elif Eren; Alasdair C Steven; Christoph Rader; Paul T Wingfield
Journal:  J Biol Chem       Date:  2017-08-23       Impact factor: 5.157

5.  Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus.

Authors:  Chunxiao Xu; Haitao Guo; Xiao-Ben Pan; Richeng Mao; Wenquan Yu; Xiaodong Xu; Lai Wei; Jinhong Chang; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

6.  Capsid Phosphorylation State and Hepadnavirus Virion Secretion.

Authors:  Xiaojun Ning; Suresh H Basagoudanavar; Kuancheng Liu; Laurie Luckenbaugh; Duoqian Wei; Chunyan Wang; Bo Wei; Yingren Zhao; Taotao Yan; William Delaney; Jianming Hu
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

Review 7.  Advances in therapeutics for chronic hepatitis B.

Authors:  Ninghan Yang; Antonio Bertoletti
Journal:  Hepatol Int       Date:  2015-09-12       Impact factor: 6.047

8.  Testing an electrostatic interaction hypothesis of hepatitis B virus capsid stability by using an in vitro capsid disassembly/reassembly system.

Authors:  Margaret Newman; Pong Kian Chua; Fan-Mei Tang; Pei-Yi Su; Chiaho Shih
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

9.  Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection.

Authors:  Danny Ka-Ho Wong; Yasuhito Tanaka; Ching-Lung Lai; Masashi Mizokami; James Fung; Man-Fung Yuen
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

10.  Characterization of Hepatitis B Precore/Core-Related Antigens.

Authors:  Xupeng Hong; Laurie Luckenbaugh; Megan Mendenhall; Renae Walsh; Liza Cabuang; Sally Soppe; Peter A Revill; Dara Burdette; Becket Feierbach; William Delaney; Jianming Hu
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.